Literature DB >> 11471109

Protective immunity to amebiasis: new insights and new challenges.

S L Stanley1.   

Abstract

Amebiasis, infection with the protozoan parasite Entamoeba histolytica, is the third leading cause of death from parasitic diseases. Despite its importance, we know little about protective immunity to amebiasis. Now, studies from a cohort of children in Bangladesh have provided some critical insights into immunity to intestinal amebiasis. Children with mucosal IgA antibodies to the amebic adherence lectin were found to be resistant to reinfection with E. histolytica. However, immunity was short-lived, and approximately 20% of children in the cohort had a second episode of E. histolytica infection during the study period. Theses findings indicate that immunity to amebiasis can develop in some children after intestinal infection, but protective immunity may be transient, and its importance in preventing disease remains to be established.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11471109     DOI: 10.1086/322046

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  3 in total

1.  Entamoeba histolytica: Clinical Update and Vaccine Prospects.

Authors:  William A. Petri
Journal:  Curr Infect Dis Rep       Date:  2002-04       Impact factor: 3.725

2.  Geographic diversity among genotypes of Entamoeba histolytica field isolates.

Authors:  Ali Haghighi; Seiki Kobayashi; Tsutomu Takeuchi; Nitaya Thammapalerd; Tomoyoshi Nozaki
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

3.  In Entamoeba histolytica, a BspA family protein is required for chemotaxis toward tumour necrosis factor.

Authors:  Anne Silvestre; Aurélie Plaze; Patricia Berthon; Roman Thibeaux; Nancy Guillen; Elisabeth Labruyère
Journal:  Microb Cell       Date:  2015-07-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.